Emeryville, California, US • 250 - 499 Employees
Major Drugs
On March 7, 2022, Zogenix, Inc. was acquired by UCB. For more information, please visit www.linkedin.com/company/ucb-pharma.
Pharmaceutical Companies Rare Disease Central Nervous System Pain Management Neurological Care Epilepsy Care Orphan Drug Development Neuroscience Drug Development And Manufacturing